Kura Insider Filing: SVP Doyle Vesting Event and Sell-to-Cover Disposition

Rhea-AI Filing Summary

Kura Oncology SVP, Finance & Accounting Thomas Doyle acquired 24,966 shares of Kura common stock on 09/27/2025 at a reported price of $0, increasing his direct holdings to 114,370 shares. On 09/29/2025 he sold 4,541 shares at $8.9422 per share as a sell-to-cover transaction to satisfy taxes tied to the vesting of 1/6th of performance-based restricted stock units (PSUs). The filing notes that one performance milestone was achieved on 09/27/2025, triggering the vesting event for that tranche; the Reporting Person also reports 500 shares indirectly held in a spouse's 401(k). After the transactions the Reporting Person beneficially owns 109,829 shares.

Positive

• 24,966 shares vested on 09/27/2025, reflecting achievement of a PSU performance milestone
• Significant retained ownership after transactions: 109,829 shares beneficially owned

Negative

• 4,541 shares sold on 09/29/2025 at $8.9422 per share (sell-to-cover for taxes)

Insights

Financial Analyst

TL;DR: Insider received PSUs that vested and sold a small tranche to cover taxes, leaving substantial ownership.

The 24,966-share acquisition at a reported price of $0 represents settlement/vesting of equity awards rather than an open-market purchase; the concurrent sell-to-cover of 4,541 shares at $8.9422 is a routine tax-related disposition. Net ownership remained large at 109,829 shares, indicating continued equity alignment with shareholders. This disclosure does not provide company-level financial metrics, valuation context, or signal a change in executive control. The activity is material only to the extent it reveals milestone achievement under PSU grants.

Corporate Governance Expert

TL;DR: Governance action: performance milestone met triggering vesting; standard sell-to-cover executed for tax withholding.

The filing documents a governance-triggered compensation event: one specified development milestone was met on 09/27/2025, causing vesting of 1/6th of PSUs granted 05/31/2023. Such milestone-based vesting is a common performance alignment mechanism. The signature and timely Form 4 filing comply with Section 16 reporting. No departures, option exercises for cash, or transfers to affiliates are disclosed. The indirect holding of 500 shares in a spouse's 401(k) is properly reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

DOYLE THOMAS JAMES

(Last) (First) (Middle)

C/O KURA ONCOLOGY, INC.

12730 HIGH BLUFF DRIVE, SUITE 400

(Street)

SAN DIEGO CA 92130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Kura Oncology, Inc. [ KURA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Finance & Accounting

3. Date of Earliest Transaction (Month/Day/Year)
09/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/27/2025		A		24,966	A	$0	114,370(1)	D
Common Stock	09/29/2025		S(2)		4,541	D	$8.9422	109,829	D
Common Stock								500	I	spouse's 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 1,211 shares acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.

2. Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares.

	/s/ Thomas Doyle	09/29/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Thomas Doyle report on Form 4 for KURA?

He reported acquiring 24,966 shares on 09/27/2025 (price reported as $0) and selling 4,541 shares on 09/29/2025 at $8.9422 per share.

Why were shares sold on 09/29/2025 in the KURA Form 4?

The sale of 4,541 shares is described as a sell-to-cover transaction to satisfy taxes associated with the vesting of 1/6th of PSUs.

How many KURA shares does the reporting person own after these transactions?

Following the reported transactions the reporting person beneficially owns 109,829 shares.

What triggered the vesting of the PSUs reported on the Form 4?

The filing states that the performance criteria for one specified development milestone was determined to be met on 09/27/2025, resulting in vesting of 1/6th of the underlying shares.

Are there any indirect holdings disclosed by the reporting person?

Yes, the filing discloses 500 shares indirectly held in the reporting person’s spouse's 401(k).